Clomipramine Hydrochloride

Panic Disorder, Depression, Obsessive-Compulsive Disorder

Treatment

2 FDA approvals

20 Active Studies for Clomipramine Hydrochloride

What is Clomipramine Hydrochloride

Clomipramine

The Generic name of this drug

Treatment Summary

Clomipramine is a tricyclic antidepressant (TCA) used to treat depression and other mental health conditions. It works by increasing the activity of neurotransmitters serotonin and norepinephrine in the brain to improve mood. Common side effects include sedation, blurred vision, dry mouth, constipation, and urinary retention. Clomipramine is also used to treat obsessive-compulsive disorder, panic disorder, chronic pain, cataplexy, trichotillomania, stuttering, premature ejaculation, and premenstrual syndrome. It is absorbed quickly from the gut and metabolized in

Anafranil

is the brand name

image of different drug pills on a surface

Clomipramine Hydrochloride Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Anafranil

Clomipramine

1989

104

Approved as Treatment by the FDA

Clomipramine, also called Anafranil, is approved by the FDA for 2 uses like Obsessive Compulsive Disorder (OCD) and Obsessive-Compulsive Disorder .

Obsessive Compulsive Disorder (OCD)

Helps manage Obsessive Compulsive Disorder (OCD)

Obsessive-Compulsive Disorder

Helps manage Obsessive Compulsive Disorder (OCD)

Effectiveness

How Clomipramine Hydrochloride Affects Patients

Clomipramine is an antidepressant medication which works by blocking certain chemicals in the brain that control mood. It usually takes around two weeks for people's mood to improve after taking this drug. It is thought that clomipramine changes how receptors in the brain respond to other chemicals, which leads to increased production of a certain chemical that affects mood. Clomipramine is also used to treat certain types of pain, especially those caused by nerve damage.

How Clomipramine Hydrochloride works in the body

Clomipramine is a drug that affects the reuptake of serotonin in the brain. It also blocks certain receptors and sodium channels, which may help to reduce chronic pain, especially neuropathic pain.

When to interrupt dosage

The proposed dose of Clomipramine Hydrochloride is based on the diagnosed disorder, such as Obsessive-Compulsive Disorder, Depression and Panic Disorder. The measure of dosage is contingent on the method of administration listed in the table below.

Condition

Dosage

Administration

Obsessive-Compulsive Disorder

25.0 mg, , 50.0 mg, 75.0 mg, 10.0 mg, 100.0 mg

Capsule, , Oral, Capsule - Oral, Tablet, Tablet - Oral

Panic Disorder

25.0 mg, , 50.0 mg, 75.0 mg, 10.0 mg, 100.0 mg

Capsule, , Oral, Capsule - Oral, Tablet, Tablet - Oral

Depression

25.0 mg, , 50.0 mg, 75.0 mg, 10.0 mg, 100.0 mg

Capsule, , Oral, Capsule - Oral, Tablet, Tablet - Oral

Warnings

Clomipramine Hydrochloride Contraindications

Condition

Risk Level

Notes

Myocardial Infarction

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

There are 20 known major drug interactions with Clomipramine Hydrochloride.

Common Clomipramine Hydrochloride Drug Interactions

Drug Name

Risk Level

Description

Anagrelide

Major

The risk or severity of QTc prolongation can be increased when Clomipramine is combined with Anagrelide.

Apixaban

Major

The metabolism of Apixaban can be decreased when combined with Clomipramine.

Arsenic trioxide

Major

The risk or severity of QTc prolongation can be increased when Clomipramine is combined with Arsenic trioxide.

Artemether

Major

The risk or severity of QTc prolongation can be increased when Clomipramine is combined with Artemether.

Asenapine

Major

The risk or severity of QTc prolongation can be increased when Clomipramine is combined with Asenapine.

Clomipramine Hydrochloride Toxicity & Overdose Risk

Anafranil overdose can cause a range of symptoms, from mild to severe, which depend on the amount taken, age of the person, and how long ago the drug was taken. Severe reactions include changes in heart rhythm, very low blood pressure, seizures, and loss of consciousness. In some cases, death has occurred due to an Anafranil overdose. Other side effects include drowsiness, blurry vision, dry mouth, constipation, difficulty urinating, dizziness when standing up, rapid heartbeat, high blood pressure, heart failure, memory problems and confusion, and mood swings in those with bipolar disorder. Withdraw

image of a doctor in a lab doing drug, clinical research

Clomipramine Hydrochloride Novel Uses: Which Conditions Have a Clinical Trial Featuring Clomipramine Hydrochloride?

634 active clinical trials are currently assessing the potential of Clomipramine Hydrochloride to alleviate Panic Disorder, Obsessive-Compulsive Disorder and Depression.

Condition

Clinical Trials

Trial Phases

Obsessive-Compulsive Disorder

66 Actively Recruiting

Not Applicable, Phase 2, Phase 3, Phase 1, Early Phase 1

Panic Disorder

13 Actively Recruiting

Not Applicable

Depression

305 Actively Recruiting

Not Applicable, Phase 1, Phase 2, Early Phase 1, Phase 4, Phase 3

Clomipramine Hydrochloride Reviews: What are patients saying about Clomipramine Hydrochloride?

5

Patient Review

2/3/2017

Clomipramine Hydrochloride for Obsessive Compulsive Disorder

This drug has done wonders for my OCD. It's helped me more than any other SRIs I've tried, to the point where I only have mild symptoms that I can manage. The side effects are a bit of a nuisance (dry mouth and constipation), but they're worth it in light of the benefits I've experienced.

5

Patient Review

6/24/2022

Clomipramine Hydrochloride for Depression

This treatment is much more effective than an SSRI.

5

Patient Review

2/6/2014

Clomipramine Hydrochloride for Obsessive Compulsive Disorder

I've been taking 100mg per day for about a month now with no negative side effects. This medication helped me almost immediately with my OCD by curbing my excessive counting behavior.

4.7

Patient Review

4/4/2017

Clomipramine Hydrochloride for Anxious

I've found this to be the best medication for intrusive thoughts, anxiety, and panic. That being said, it can have some nasty side effects that one should be aware of before taking it. Please speak with a professional to see if this is the right drug for you.

4.7

Patient Review

9/18/2015

Clomipramine Hydrochloride for Panic Disorder

It took a little while for this to start working, but it was very effective in treating my OCD. I also saw a massive improvement in my insomnia and panic attacks.

4.3

Patient Review

10/9/2017

Clomipramine Hydrochloride for Anxious

I've been taking 100mg of clomipramine every day, and it has really helped me sleep better. The only downside is that I developed ringing in my ears, which may be a side effect of the drug.

4.3

Patient Review

11/1/2022

Clomipramine Hydrochloride for Obsessive Compulsive Disorder

This medication saved me. I had been struggling with chronic IBS and OCD for years, trying all sorts of different treatments to no avail. But as soon as I started taking Clomiprine, everything changed. Within a week my diarrhea and unwanted thoughts were gone. If you're struggling with anything similar, I urge you to give this medication a try.

4.3

Patient Review

4/3/2014

Clomipramine Hydrochloride for Obsessive Compulsive Disorder

I was struggling with some serious mental health issues, and this medication really turned things around for me. I felt a difference from the very first day, and now my intrusive thoughts are gone.

4.3

Patient Review

10/6/2018

Clomipramine Hydrochloride for Obsessive Compulsive Disorder

Despite the dry mouth and constipation, this medication is worth it because it helps me stay balanced and employed.

3.3

Patient Review

2/16/2020

Clomipramine Hydrochloride for Depression

I've been using this medication for a couple years now. It's helped me feel better, but I have noticed some negative side effects like memory problems and an irregular heartbeat.

3

Patient Review

3/21/2013

Clomipramine Hydrochloride for Anxious

I found that clomipramine was more effective than alprazolam for me, but everyone is different.

1.7

Patient Review

5/4/2017

Clomipramine Hydrochloride for Obsessive Compulsive Disorder

I have severe OCD and this medication, which my doctor just raised the dosage of last week, did not help alleviate my symptoms at all. In addition to that, it caused some very unpleasant side effects like a fast heartbeat, muscle pain, and anorexia.

1.7

Patient Review

3/23/2020

Clomipramine Hydrochloride for Obsessive Compulsive Disorder

Made me feel very unstable and my thoughts were racing while I was on it.

1.7

Patient Review

10/8/2012

Clomipramine Hydrochloride for Obsessive Compulsive Disorder

I think this medication led to me overeating and gaining weight.

1

Patient Review

7/3/2014

Clomipramine Hydrochloride for Obsessive Compulsive Disorder

Unfortunately, this drug did not work well for me. I had heart palpitations on a small dosage of 10mg and it only got worse when the doctor increased my dosage to 20mg. I felt incredibly tired and had no appetite while taking this medication, and now that I'm off of it I feel like I have the flu.

1

Patient Review

5/17/2017

Clomipramine Hydrochloride for Obsessive Compulsive Disorder

Unfortunately, this medicine exacerbated my bipolar and OCD symptoms. I would go for a couple days without sleep, then sleep for a couple days in a row. It was constant twitching in my legs and feet that i didn't have before i started this medicine
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about clomipramine hydrochloride

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is clomipramine a strong antidepressant?

"Although Clomipramine is most commonly used as a treatment for obsessive-compulsive disorder, it is also an effective antidepressant. It works by affecting certain receptors in the brain, as shown in the table below."

Answered by AI

What are the most common side effects of clomipramine?

"The following side effects may occur when taking clomipramine: feeling dizzy or tired, dry mouth, trouble Line, upset stomach, nausea or vomiting, changes in appetite or weight, flushed skin, sweating, tiredness, or blurred vision. Symptoms of anxiety may get worse when you first start taking clomipramine."

Answered by AI

How does clomipramine make you feel?

"Clomipramine may make you feel sleepy, so your doctor may start you on a small dose. They may then gradually increase your dose as your body gets used to it. Clomipramine is usually taken once a day at bedtime, but it can also be taken in smaller doses two to three times a day."

Answered by AI

What is clomipramine prescribed for?

"It affects chemicals in the brain that may become unbalanced and cause OCD.

Clomipramine is used to treat obsessive compulsive disorder (OCD). OCD is a nervous condition wherein a person has recurring thoughts or ideas or does repetitive things because they are anxious. Clomipramine is a tricyclic antidepressant (TCA). It affects chemicals in the brain that may become unbalanced, which can lead to OCD."

Answered by AI

Clinical Trials for Clomipramine Hydrochloride

Image of Stanford University School of Medicine in Stanford, United States.

BEAR Program for Suicidal Thoughts

18 - 75
Female
Stanford, CA

The current study aims to test the feasibility of a new form of group therapy for women who have a history of interpersonal trauma and current suicidal ideation. The Building Empowerment and Resilience (BEAR) Therapeutic group has been adapted for women who have experienced trauma and have current suicidal ideation. It incorporates psychological skills, psychoeducation about trauma and gender-based violence, and physical self-defense training, all within a therapeutic process. It will be implemented with women who have experienced interpersonal trauma (physical, sexual, or emotional abuse/neglect) and experience various mental health difficulties, including suicidal ideation. We aim to assess the feasibility to recruit and implement the BEAR group. Our ultimate aim is to assess whether the program can effect self-efficacy and suicidal ideation.

Waitlist Available
Has No Placebo

Stanford University School of Medicine

Jennifer Keller, PhD

Image of Western Psychiatric Hospital/University of Pittsburgh in Pittsburgh, United States.

Sleep and Circadian Interventions for Suicide

18 - 25
All Sexes
Pittsburgh, PA

The purpose of this study is to examine the extent to which delivering sleep and circadian focused interventions in addition to evidenced based psychiatric care for depression and suicide risk may contribute to decreasing suicide risk among high risk young adults. Investigators will evaluate three interventions targeting sleep in acutely suicidal college students enrolled in intensive outpatient treatment. Participants will be randomly assigned to one of three intervention groups: 1. Triple Chronotherapy (TCT)+ Transdiagnostic Sleep and Circadian Intervention (TSC) 2. Transdiagnostic Sleep and Circadian Intervention (TSC) 3. Sleep Feedback (SF) Participants will be followed for 6 months with primary outcome domains of suicidal thoughts and behaviors and depression evaluated by blinded clinicians at short (Days 1-4 of intervention), medium (2 months) and long (6 month) term intervals.

Waitlist Available
Has No Placebo

Western Psychiatric Hospital/University of Pittsburgh

Tina Goldstein, PhD

Image of University of South Florida in Tampa, United States.

WeACT Program for Caregivers of People With Dementia

18+
All Sexes
Tampa, FL

The goal of this clinical trial is to learn whether WeACT, a self-paced, web-based program, is feasible and helpful for adult family caregivers of a relative living with dementia. WeACT is based on acceptance and commitment therapy (ACT), which teaches skills to handle difficult thoughts and feelings and take steps toward what matters most. The main questions this study aims to answer are: * Can caregivers complete WeACT as planned? * Do caregivers show improvements in mental health and coping after using WeACT? * What are caregivers' experiences with the program, and what suggestions do they have to improve it? Participants will: * Complete six self-paced weekly online modules and use the daily practice section during the program. * Complete online questionnaires before starting and after completing the program. * Take part in one online interview about their experience.

Waitlist Available
Has No Placebo

University of South Florida

Areum Han

Have you considered Clomipramine Hydrochloride clinical trials?

We made a collection of clinical trials featuring Clomipramine Hydrochloride, we think they might fit your search criteria.
Go to Trials
Image of Wahwala Iyohlogya/Peaceful Means in Pine Ridge, United States.

Lakota Family Acceptance Program for Depression and Anxiety

Any Age
All Sexes
Pine Ridge, SD

The goal of this open pilot trial (OPT) is to develop a Lakota-adapted Family Acceptance Project (LFAP) for Indigenous 2SLGBTQ+ youth and their caregivers. The OPT is specifically focused on acceptability, feasibility, and safety of programming and research protocols. The investigators will also examine pre- to post- changes on outcomes for the sole purposes of making sure scores on measures are changing in the hypothesized direction (e.g., depression scores are going from moderate to minimal as opposed to no change or depression scores increasing). Once enrolled in the study, participants complete a baseline survey. Then participants will engage in LFAP which is an 8-session group intervention; sessions will be scheduled once a week for eight weeks (at 2 hours per session). Participants will complete survey instruments before and immediately after the program sessions, in addition to post-program surveys and an exit interview.

Recruiting
Has No Placebo

Wahwala Iyohlogya/Peaceful Means (+1 Sites)

Katie Edwards, PhD

Image of Seaway Valley Community Health Centre (Cardiac Rehab Program) in Cornwall, Canada.

FRAME for Heart Failure

18+
All Sexes
Cornwall, Canada

Heart failure is a high-risk, chronic condition that impacts patients' mental health. Approximately 50% of heart failure patients experience comorbid mental health conditions, such as stress, depression and anxiety, which affect their day-to-day lives. Despite this interconnection, the integration of mental health awareness and support into cardiac care remains limited. To address this gap, the FRAME (Foundation, Recognition, Awareness, Management, Engagement) intervention was co-designed by researchers, healthcare providers, health system decisionmakers, and patient partners. This pilot study evaluates the feasibility of implementing the FRAME intervention in pilot clinical sites within two health regions in Ontario, Canada, including team-based family medicine clinics, cardiac rehabilitation/specialist clinics, and emergency departments. Utilizing a pretest-posttest hybrid 1 model intervention design, this study evaluates process indicators and patient-focused outcomes through surveys and semi-structured qualitative interviews. Findings from this study will inform a future large scale cohort study and scalable integration of the FRAME tool into existing cardiac care pathways to enhance mental health awareness and support among heart failure patients.

Recruiting
Has No Placebo

Seaway Valley Community Health Centre (Cardiac Rehab Program) (+8 Sites)

Image of Lincoln Middle School in Cottage Grove, United States.

Behavioral Interventions for Depression in Students

Any Age
All Sexes
Cottage Grove, OR

The goal of this clinical trial is to learn if two behavioral interventions work to reduce office disciplinary referrals, improve attendance, and reduce depression and anxiety in 7th grade students. This project combines two evidence-based programs-the Inclusive Skill-building Learning Approach (ISLA) for school-wide discipline reform and the Family Check-Up Online (FCU-O) for family-centered support-in an adaptive design to examine the unique and additive effects of these interventions on these child behavior outcomes. The main questions it will answer are: 1. What is the relative efficacy of ISLA vs. School-as-Usual? 2. What is the optimal sequencing of these interventions? 3. Which overall sequence of intervention strategies was most effective? Researchers will compare 6 combinations of these interventions to see which combination and sequencing provides the best student outcomes. School personnel participating in the project will be trained to implement the two interventions at their school. They will answer surveys in the fall, winter, and spring of their year of participation. Parent and Youth participants will complete surveys at baseline and then again 6 months and 12 months later.

Waitlist Available
Has No Placebo

Lincoln Middle School (+12 Sites)

Beth Stormshak, PhD

Image of Cedars-Sinai Medical Center in Los Angeles, United States.

Living Well Program for Anxiety in Breast Cancer

18+
Female
Los Angeles, CA

The goal of this study is to evaluate the efficacy and cost-effectiveness of the Living Well Program, a digital therapeutic application with telecoaching support, in breast cancer patients with moderate-to-severe anxiety. The main question the study aims to answer is: does digital cognitive-behavioral therapy-based interventions decrease the overall healthcare costs of patients with stage II to IV breast cancer? The study has one group of participants who will use the Living Well app and telecoaching support. This group will be compared to retroactively matched controls. Over 3 months, patients will complete 21 mental health modules and 5 telecoaching sessions. In the following 3 months, they will complete any outstanding telecoaching sessions and modules while still being monitored, even if they finished all modules and sessions in the first 3 months. The 6 months after that will be the follow-up phase. They will still have access to the Living Well app and may continue to use it, and they will complete the same assessment questionnaires as baseline to identify any changes in their overall mental health.

Waitlist Available
Has No Placebo

Cedars-Sinai Medical Center

Scott Irwin, MD

Have you considered Clomipramine Hydrochloride clinical trials?

We made a collection of clinical trials featuring Clomipramine Hydrochloride, we think they might fit your search criteria.
Go to Trials
Image of University of California San Diego in La Jolla, United States.

AI Chatbot for Postpartum Loneliness

18+
Female
La Jolla, CA

The goal of this clinical trial is to learn whether a postpartum chatbot powered by generative artificial intelligence (genAI) can help new mothers get better pelvic floor health information and feel less lonely after childbirth. The main questions this study aims to answer are: * Does using the chatbot improve postpartum pelvic floor health knowledge? * Does using the chatbot help reduce feelings of loneliness during the postpartum period? * Does using the chatbot impact pelvic floor symptoms? Researchers will compare standard postpartum care to standard care plus the chatbot. Participants will: Be assigned by chance (like flipping a coin) to standard postpartum care with or without access to the chatbot. If in the chatbot group, participants will receive education and support via the chatbot over a 4-week period. Both groups will complete questionnaires to measure their pelvic floor knowledge, pelvic floor symptoms, feelings of loneliness, depression, infant bonding, perceived social support, adverse childhood experiences, and peri-traumatic distress. The chatbot was created by urogynecology experts in collaboration with UC San Diego computer science and biomedical informatics researchers. The chatbot is designed to give new mothers personalized, evidence-based information and support in real time.

Waitlist Available
Has No Placebo

University of California San Diego

Image of Mayo Clinic in Florida in Jacksonville, United States.

Virtual Reality for Cancer

18 - 90
All Sexes
Jacksonville, FL

This clinical trial tests the safety, tolerability, and effectiveness of a virtual reality intervention to improve psychological symptom burden for cancer patients undergoing treatment. Virtual reality (VR) is a technology that allows users to experience and interact with three-dimensional, computer-generated environments that simulate the real world or imagined settings. The VR intervention consists of a preloaded with immersive environments designed to engage the senses through simulated sights and sounds. This may include a walk through of a serene forest, exploring vibrant coral reefs, swimming with dolphins, or standing at the base of a majestic waterfall. These environments are created to provide a relaxing and engaging experience. Completing the VR intervention may be a safe and effective way to improve quality of life, reduce anxiety, enhance focus, and promote healthy living for cancer patients undergoing treatment.

Recruiting
Has No Placebo

Mayo Clinic in Florida

Juan C. Cardenas Rosales, MD

Have you considered Clomipramine Hydrochloride clinical trials?

We made a collection of clinical trials featuring Clomipramine Hydrochloride, we think they might fit your search criteria.
Go to Trials